Medicus Pharma Ltd. (MDCX)
2.50
-0.12
(-4.58%)
USD |
NASDAQ |
Oct 23, 16:00
2.58
+0.08
(+3.20%)
After-Hours: 20:00
Medicus Pharma Net Income (Quarterly) : -8.440M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.440M |
| March 31, 2026 | -6.592M |
| December 31, 2025 | -5.870M |
| September 30, 2025 | -11.60M |
| June 30, 2025 | -4.460M |
| March 31, 2025 | -3.556M |
| December 31, 2024 | -1.626M |
| September 30, 2024 | -1.671M |
| Date | Value |
|---|---|
| June 30, 2024 | -2.656M |
| March 31, 2024 | -1.266M |
| December 31, 2023 | -1.867M |
| September 30, 2023 | -2.210M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -0.2373M |
| September 30, 2022 | -0.297M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 37.41M |
| enGene Therapeutics, Inc. | -32.50M |
| Xenon Pharmaceuticals, Inc. | -110.74M |
| Psyence Biomedical Ltd. | -0.7533M |
| AVITA Medical, Inc. | -7.663M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.392M |
| EPS Diluted (Quarterly) | -0.1524 |
| Enterprise Value | 155.00M |
| Earnings Yield | -64.83% |
| Normalized Earnings Yield | -54.51 |